![1-[2-(methylsulfonyl)phenyl]piperazine](https://static.cymitquimica.com/cas-image/84891-1-2-methylsulfonyl-phenyl-piperazine.png)
CAS: 313490-26-5 - 1-[2-(methylsulfonyl)phenyl]piperazine
Formula:C11H16N2O2S
InChI:InChI=1/C11H16N2O2S/c1-16(14,15)11-5-3-2-4-10(11)13-8-6-12-7-9-13/h2-5,12H,6-9H2,1H3
- Sinonimi:
- Piperazine, 1-[2-(methylsulfonyl)phenyl]-
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 1-[2-(Methylsulphonyl)phenyl]piperazine REF: IN-DA003DSXCAS: 313490-26-5 | 97% | 107,00 €~563,00 € | Lun 16 Dic 24 |
 | 1-[2-(Methylsulfonyl)phenyl]piperazine REF: 10-F033993CAS: 313490-26-5 | 95.0% | Prezzo su richiesta | Ven 27 Dic 24 |
 | 1-[2-(Methylsulphonyl)phenyl]piperazine REF: 3D-NMA49026CAS: 313490-26-5 | Min. 95% | Prezzo su richiesta | Lun 27 Gen 25 |
![1-[2-(Methylsulphonyl)phenyl]piperazine](https://static.cymitquimica.com/products/IN/thumb/DA003DSX.jpg)
1-[2-(Methylsulphonyl)phenyl]piperazine
CAS:313490-26-5
Formula:
C11H16N2O2S
Purezza:
97%
Colore e forma:
Solid
Peso molecolare:
240.3219
Ref: IN-DA003DSX
| 1g | 201,00 € | ||
| 5g | 563,00 € | ||
| 100mg | 107,00 € | ||
| 250mg | 115,00 € |
Consegna stimata in Stati Uniti, il Lunedì 16 Dicembre 2024
![1-[2-(Methylsulfonyl)phenyl]piperazine](https://static.cymitquimica.com/products/10/thumb/F033993.jpg)
1-[2-(Methylsulfonyl)phenyl]piperazine
CAS:313490-26-5
Purezza:
95.0%
Colore e forma:
Solid
Peso molecolare:
240.32000732421875
Ref: 10-F033993
| 1g | 278,00 € | ||
| 5g | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta | ||
| 250mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Venerdì 27 Dicembre 2024
![1-[2-(Methylsulphonyl)phenyl]piperazine](https://static.cymitquimica.com/products/3D/thumb/NMA49026.jpg)
1-[2-(Methylsulphonyl)phenyl]piperazine
CAS:313490-26-5
Versatile small molecule scaffold
Formula:
C11H16N2O2S
Purezza:
Min. 95%
Peso molecolare:
240.33 g/mol
Ref: 3D-NMA49026
| 50mg | 230,00 € | ||
| 500mg | 918,00 € |
Consegna stimata in Stati Uniti, il Lunedì 27 Gennaio 2025
